Not applicableStudy completedNCT03273972
What this trial is testing
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
Who this might be right for
AtherosclerosisCardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 30